2 Followers on Owler

Ceregene

is developing cures for Parkinson's and Alzheimer's disease using combined power of neurotrophic factors and genetic therapy... Read more
OverviewCompetitorsFundingNews & Insights

Ceregene

is developing cures for Parkinson's and Alzheimer's disease using combined power of neurotrophic factors and genetic therapy... Read more
Ceregene CEO: Jeffrey Ostrove

CEO

Jeffrey Ostrove

CEO Approval Rating

70/100

01/2001

PrivateSubsidiary of Sangamo BioSciences, Inc.

Health Care Equipment & ServicesPharmaceuticals & Biotechnology
BiotechnologyPharmaceuticals

Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
25-100
Agree?
Funding
$82.1M

News

Feb 10, 2014
BUSINESS WIRE
Press Release: Ceregene : Research and Markets: The Global Gene Therapy Industry Has the Potential to Become a Multi-Million Dollar Industry by the End of 2017 Says Latest Offering

Ceregene Competitors

1Neurotech Pharmaceuticals, Inc.
2Satoripharma
3EyePoint
4Sarepta
5Cerecin
6Sage Therapeutics
7Seaside Therapeutics
8Adlyfe, Inc.
9Minerva Neurosciences
10Voyager
Unlock 8 + competitors

Trending Companies